Tag Archives: Late Stage Pipeline

Transformational Late Stage Drugs Delivered Through Deal-Making
March 21, 2014

Today’s biopharma industry has a richer and more exciting late stage pipeline of compelling new therapeutics than its had in years, drawing lots of enthusiasm from analysts and investors.  Goldman Sachs (GS) recently published a report on the “10 drugs

5 Comments